← FDA Drug Approvals (Drugs@FDA)

EYLEA HD

BLA · Biologics License Application · Sponsor: REGENERON PHARMACEUTICALS · Approved 2023-08-18

Drug application

FDA Application #

BLA761355

Application type

Biologics License Application

Brand name

EYLEA HD

Generic name

AFLIBERCEPT

Active ingredients

AFLIBERCEPT

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

REGENERON PHARMACEUTICALS

Manufacturer

Regeneron Pharmaceuticals, Inc

First approval

2023-08-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown